MRNA250103C60000
- 0.01
- 0.000.00%
Moderna Newsroom
Bird Flu Claims First U.S. Life in Louisiana
Why Moderna (MRNA) Stock Is Trading Higher
Moderna CEO Letter Says With A Full Season Of RSV Contracting In 2025, Expect To Increase MRESVIA's Market Share In U.S. And Market Access Globally; Plan To Bring Manufacturing Plants Online In The UK, Canada And Australia In 2025
Healthcare Sector's 2024 Gainers and Losers: Intuitive Surgical, Boston Scientific Tops Chart
Vaccine Stocks Gain Amid Uptick in Flu, COVID-19, RSV
Moderna Targets 10 New Approvals by 2027
Express News | Moderna Shares up 3.8% Premarket
Moderna (MRNA) Rises But Trails Market: What Investors Should Know
Unusual Options Activity: PG, DAL and Others Attract Market Bets, PG V/OI Ratio Reaches 133.3
EST Jan 3rd Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Moderna Options Spot-On: On January 3rd, 117.68K Contracts Were Traded, With 657.56K Open Interest
On January 3rd ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 117.68K options for the day, of which put options accounted for 31.48% of the total transactions, and
The S&P 500's 10 Worst Performing Stocks in 2023 Fell Again in 2024
Moderna Options Spot-On: On January 2nd, 112.55K Contracts Were Traded, With 646.17K Open Interest
On January 2nd ET, $Moderna(MRNA.US)$ had active options trading, with a total trading volume of 112.55K options for the day, of which put options accounted for 77.7% of the total transactions, and
These Battered S&P 500 Stocks Could Be Ripe for a Turnaround in 2025
Why Moderna Inc. (MRNA) Is Skyrocketing
The U.S. stock market officially closed for 2024! Among the components of the three major stock indices, who performed the best and who performed the worst?
AppLovin, a constituent stock of the Nasdaq, surged by 713%, becoming the biggest dark horse, with an increase more than four times that of AI leader NVIDIA.
Equity Markets Fall Intraday as 2024 Draws to Close
Peering Into Moderna's Recent Short Interest
These Stocks Are Moving the Most Today: Super Micro, Moderna, Nvidia, MicroStrategy, Palantir, VeriSign, Sangamo, and More -- Barrons.com
These Are the Best and Worst Stocks This Year
This Biotech Is One of the S&P 500's Worst Performers. It Looks Too Cheap. -- Barrons.com